Real-World study checks OZURDEX safety in chinese DME patients

NCT ID NCT06548568

Ongoing Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 110 adults with diabetic macular edema who are prescribed OZURDEX (a dexamethasone implant placed in the eye) by their doctors in routine Chinese clinics. Researchers will track side effects like cataracts, high eye pressure, and bleeding over two years. The goal is to see how safe the drug is in real-world use, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexamethasone intravitreal implant (OZURDEX)
What this could lead to: If successful, this study will confirm that OZURDEX is safe for long-term use in Chinese patients with diabetic macular edema in everyday practice.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by other factors. It only tracks safety, not whether the drug works better than alternatives.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic macular edema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC MACULAR EDEMA

Contacts and locations

Locations

General Hospital of Central Theater Command /ID# 273618

Wuhan, Hubei, 430000, China
Henan Provincial Eye Hosptial /ID# 272424

Zhengzhou, Henan, 450003, China
Peking University People'S Hospital /ID# 274505

Beijing, Beijing Municipality, 100034, China
Qingdao Eye Hospital Of Shandong First Medical University /ID# 268173

Qingdao, Shandong, 266071, China
Shanghai General hospital /ID# 270376

Shanghai, Shanghai Municipality, 200080, China
Shanxi Eye Hospital /ID# 270564

Taiyuan, 030072, China
The Affiliated Eye Hospital Of Wenzhou Medical University /ID# 274466

Wenzhou, Zhejiang, 325027, China
The First Affiliated Hospital of Dalian Medical University /ID# 270563

Dalian, Liaoning, 116000, China
The Second Affiliated Hospital of Zhejiang University School of Medicine /ID# 273617

Hangzhou, Zhejiang, 310009, China
West China Hospital of Sichuan University /ID# 273656

Chengdu, Sichuan, 610041, China
Xi'an Fourth Hospital /ID# 270562

Xi'an, Shaanxi, 710004, China
Xiamen Eye Center of Xiamen University /ID# 268172

Xiamen, Fujian, 390000, China
Zhongshan Ophthalmic Center,SunYat-Sen University /ID# 274555

Guangzhou, Guangdong, 510623, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.